Don C. Wiley

Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical.

D. Garboczi, W. Biddison, Yuan-hua Ding, 1999, Immunity.

Structural, biochemical, and biophysical studies of HLA-A2/altered peptide ligands binding to viral-peptide-specific human T-cell receptors.

B M Baker, D. Wiley, D. Garboczi, 1999, Cold Spring Harbor symposia on quantitative biology.

Crystal Structures of Hla-a*0201 Complexed with Antigenic Peptides with Either the Amino-or Carboxyl-terminal Group Substituted by a Methyl Group

D. Wiley, Kathrine J. Smith, Hwai-Chen Guo, 2022 .

Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding.

D. Wiley, J. Strominger, J. Rothbard, 1990, The EMBO journal.

Specific Binding of a Soluble Recombinant β-Chain T-Cell Antigen Receptor to Toxic Shock Syndrome Toxin-1, a Superantigen

D. Garboczi, Jongsun Kim, Don C. Wiley, 1996, Molecules and Cells.

Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules.

D. Wiley, M. Bouvier, D C Wiley, 1994, Science.

Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling.

D. Wiley, B. Baker, W. Biddison, 2000, Immunity.